► 6:39 Treating AML After Evolution From MPD AML Content Hub Raajit K. Rampal, MD, PhD, of @sloankettering, discusses #treatment for patients with #AML which has evolved from #myeloproliferative disease.
► 0:42 Tomivosertib Exhibits Potent Anti-leukemic Properties on AML Cells AML Content Hub Researchers from @LurieCancer and @nufeinbergmed present anti-leukemic properties of #tomivosertib as #therapy for #AML.
► 13:09 Patient-Derived Cancer Models Oncology Nicola Valerie, MD, of @ICR_London discusses #models for #cancer #research.
► 4:00 Patch Testing for Contact Dermatitis Allergy / Immunology Rachel L. Schreiber, MD, from @TeamAllergy discusses #patchtesting for #contactdermatitis.
► 1:41 Delaying Neurosurgery for Patients Neurology Sarah Woodrow, MD, of @ClevelandClinic, discusses #neurosurgery and alternative treatment options.
► 1:34 Latex Allergy or Sanitizer Dermatitis? Allergy / Immunology @DermaBlore discusses identification of #latexallergy versus #sanitizer #dermatitis in the #COVID19 #pandemic.
► 27:41 COVID-19 Considerations Related to the Kidney Nephrology Sunit Kabaria, MD, of @RWJUH, discusses how #COVID19 impacts the #kidneys.
► 12:15 Case Discussion: 49-Year-Old Male With UTUC Oncology @MattMossanen; @sonpavde; Steven L Chang, MD, MS; Michelle S. Hirsch, MD, PhD; and Mark A. Preston, MD, PhD, discuss a patient with #UTUC.
► 1:02:03 Cytopenia as an Indicator of Primary Immunodeficiency Primary Immunodeficiency Content Hub Jolan Walter, MD, PhD, of @AllChildrens, discusses #cytopenias and #primaryimmunodeficiency.
► 45:42 The Use of Intensive Treatment in Elderly Patients With AML AML Content Hub @GOssenkoppele discusses #AML treatment in #elderly patients.